Submissions from 2023
A Case of Cushing’s Syndrome, Amanda Tep, DO
"A Rare Case of Cushing's Syndrome Caused by a Pulmonary Carcinoid Tumor", Amanda Tep, DO
Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study., Krishnansu S Tewari, Michael W Sill, Michael J Birrer, Richard T Penson, Helen Huang, David H Moore, Lois M Ramondetta, Lisa M Landrum, Ana Oaknin, Thomas J Reid, Mario M Leitao, Helen E Michael, and Bradley J Monk
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection., Tanayott Thaweethai, Sarah E Jolley, Elizabeth W Karlson, Emily B Levitan, Bruce Levy, Grace A McComsey, Lisa McCorkell, Girish N Nadkarni, Sairam Parthasarathy, Upinder Singh, Tiffany A Walker, Caitlin A Selvaggi, Daniel J Shinnick, Carolin C M Schulte, Rachel Atchley-Challenner, George A Alba, Radica Alicic, Natasha Altman, Khamal Anglin, Urania Argueta, Hassan Ashktorab, Gaston Baslet, Ingrid V Bassett, Lucinda Bateman, Brahmchetna Bedi, Shamik Bhattacharyya, Marie-Abele Bind, Andra L Blomkalns, Hector Bonilla, Patricia A Bush, Mario Castro, James Chan, Alexander W Charney, Peter Chen, Lori B Chibnik, Helen Y Chu, Rebecca G Clifton, Maged M Costantine, Sushma K Cribbs, Sylvia I Davila Nieves, Steven G Deeks, Alexandria Duven, Ivette F Emery, Nathan Erdmann, Kristine M Erlandson, Kacey C Ernst, Rachael Farah-Abraham, Cheryl E Farner, Elen M Feuerriegel, Judes Fleurimont, Vivian Fonseca, Nicholas Franko, Vivian Gainer, Jennifer C Gander, Edward M Gardner, Linda N Geng, Kelly S Gibson, Minjoung Go, Jason D Goldman, Halle Grebe, Frank L Greenway, Mounira Habli, John Hafner, Jenny E Han, Keith A Hanson, James Heath, Carla Hernandez, Rachel Hess, Sally L Hodder, Matthew K Hoffman, Susan E Hoover, Beatrice Huang, Brenna L Hughes, Prasanna Jagannathan, Janice John, Michael R Jordan, Stuart D Katz, Elizabeth S Kaufman, John D Kelly, Sara W Kelly, Megan M Kemp, John P Kirwan, Jonathan D Klein, Kenneth S Knox, Jerry A Krishnan, Andre Kumar, Adeyinka O Laiyemo, Allison A Lambert, Margaret Lanca, Joyce K Lee-Iannotti, Brian P Logarbo, Michele T Longo, Carlos A Luciano, Karen Lutrick, Jason H Maley, Jai G Marathe, Vincent Marconi, Gailen D Marshall, Christopher F Martin, Yuri Matusov, Alem Mehari, Hector Mendez-Figueroa, Robin Mermelstein, Torri D Metz, Richard Morse, Jarrod Mosier, Christian Mouchati, Janet Mullington, Shawn N Murphy, Robert B Neuman, Janko Z Nikolich, Ighovwerha Ofotokun, Elizabeth Ojemakinde, Anna Palatnik, Kristy Palomares, Tanyalak Parimon, Samuel Parry, Jan E Patterson, Thomas F Patterson, Rachel E Patzer, Michael J Peluso, Priscilla Pemu, Christian M Pettker, Beth A Plunkett, Kristen Pogreba-Brown, Athena Poppas, John G Quigley, Uma Reddy, Rebecca Reece, Harrison Reeder, W B Reeves, Eric M Reiman, Franz Rischard, Jonathan Rosand, Dwight J Rouse, Adam Ruff, George Saade, Grecio J Sandoval, Shannon M Schlater, Fitzgerald Shepherd, Zaki A Sherif, Hyagriv Simhan, Nora G Singer, Daniel W Skupski, Amber Sowles, Jeffrey A Sparks, Fatima I Sukhera, Barbara S Taylor, Larissa Teunis, Robert J Thomas, John M Thorp, Paul Thuluvath, Amberly Ticotsky, Alan T Tita, Katherine R Tuttle, Alfredo E Urdaneta, Daisy Valdivieso, Timothy M VanWagoner, Andrew Vasey, Monica Verduzco-Gutierrez, Zachary S Wallace, Honorine D Ward, David E Warren, Steven J Weiner, Shelley Welch, Sidney W Whiteheart, Zanthia Wiley, Juan P Wisnivesky, Lynn M Yee, Sokratis Zisis, Leora I Horwitz, Andrea S Foulkes, and RECOVER Consortium
Use of a Pulmonary Artery Pressure Sensor to Manage Patients With Left Ventricular Assist Devices., Vinay Thohan, Jacob Abraham, Adam Burdorf, Nasir Sulemanjee, Brian Jaski, Maya Guglin, Francis D Pagani, Himabindu Vidula, David T Majure, Rebecca Napier, Thomas J Heywood, Rebecca Cogswell, Nicholas Dirckx, David J Farrar, Stavros G Drakos, and INTELLECT 2-HF Investigators
Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma., Holly M Thomson, Shannon P Fortin Ensign, Victoria S Edmonds, Akanksha Sharma, Richard J Butterfield, Steven E Schild, Jonathan B Ashman, Richard S Zimmerman, Naresh P Patel, Alan H Bryce, Sujay A Vora, Terence T Sio, and Alyx B Porter
Abstract: 927 Streamlining Cancer Immunotherapy Research with the CRI IAtlas Data Resource and Web Portal, Vésteinn Thorsson, Carolina Heimann, Andrew Lamb, David L Gibbs, Dante Bortone, Sarah Dexheimer, Steven Vensko, Yooree Chae, Ilya Shmulevich, Benjamin Vincent, and James Eddy
Targeting of insulin receptor endocytosis as a treatment to insulin resistance., Bryce Tim, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
Evaluation of a Virtual Abstract Writing Workshop for Registered Nurses, Rosemary Timmerman, Dawn Bock, Teresa Rangel, and Trisha Saul
Editorial: Diet and multiple sclerosis., Tyler J Titcomb, Barbara Giesser, Scott M Plafker, Ilana B Katz Sand, and Terry L Wahls
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer., Sara M Tolaney, Arlene Chan, Katarina Petrakova, Suzette Delaloge, Mario Campone, Hiroji Iwata, Parvin F Peddi, Peter A Kaufman, Elisabeth De Kermadec, Qianying Liu, Patrick Cohen, Gautier Paux, Lei Wang, Nils Ternès, Eric Boitier, and Seock-Ah Im
Cannabis positivity rates in 17 emergency departments across the United States with varying degrees of marijuana legalization., Nicole V Tolan, Matthew D Krasowski, Patrick C Mathias, Joesph R Wiencek, Nikolina Babic, Peter R Chai, Allison B Chambliss, Ibrahim Choucair, Christiana A Demetriou, Timothy B Erickson, Matthew Feldhammer, Deborah French, Bryan D Hayes, Phillip Kang, Joe M El-Khoury, Claire E Knezevic, Andrew Monte, Robert D Nerenz, Anthony O Okorodudu, Stephen M Roper, Alec Saitman, Vamsi Thiriveedhi, Sacha N Uljon, Alexis Vest, Alison Woodworth, Min Yu, and Stacy E F Melanson
Maternal Group B Streptococcus Prophylaxis Improvement using an Electronic Medical Record Dynamic Order Set., Mark Tomlinson, Rachael Baker, Jennifer Ulrich, Maulin P. Shah, Horia Marginean, and Stephen Girolami
Bone Cement Waste in Total Knee Arthroplasty: A Preliminary Study of Scope and Cost., Geoffrey S Tompkins, Kevin K Howe, Rebecca Valderrama, Katie Sypher, T Michael Griffin, and Shih-Ting Chiu
Impact of Female Sex on Cardiogenic Shock Outcomes: A Cardiogenic Shock Working Group Report., Van-Khue Ton, Manreet K Kanwar, Borui Li, Vanessa Blumer, Song Li, Elric Zweck, Shashank S Sinha, Maryjane Farr, Shelley Hall, Rachna Kataria, Maya Guglin, Esther Vorovich, Jaime Hernandez-Montfort, A Reshad Garan, Mohit Pahuja, Saraschandra Vallabhajosyula, Sandeep Nathan, Jacob Abraham, Neil M Harwani, Gavin W Hickey, Detlef Wencker, Andrew D Schwartzman, Wissam Khalife, Claudius Mahr, Ju H Kim, Arvind Bhimaraj, Paavni Sangal, Yijing Zhang, Karol D Walec, Peter Zazzali, Daniel Burkhoff, and Navin K Kapur
Hemodynamic Predictors of In-Hospital Mortality in Cardiogenic Shock: The Trajectory Is What Matters, VK Ton, Jacob Abraham, and See full list of authors in comments
Project Highlights From the GRAPPA 2022 Annual Meeting: Education Initiatives and Axial Involvement in Psoriatic Arthritis., Murat Torgutalp, Dafna D Gladman, Oliver FitzGerald, Philip Mease, and Denis Poddubnyy
Two-year results from Onyx ONE clear in patients with high bleeding risk on one-month DAPT with and without intracoronary imaging., Gabor G Toth, David E Kandzari, Ajay J Kirtane, Stephan Windecker, Azeem Latib, Elvin Kedhi, Roxana Mehran, Matthew J Price, James W Choi, Ronald Caputo, Roel Troquay, Erik Diderholm, Sunil Singh, Somjot S Brar, Arthur Loussararian, Stanley Chetcuti, Mark Tulli, Gregg W Stone, Te-Hsin Lung, and Darren Mylotte
Harnessing the T-cell response against cancer mutations, E Tran
Neoantigen T-cell receptor therapy in solid cancer, E Tran
T-cell receptor gene therapy targeting HLA-II-restricted HPV antigens, E Tran
T-cell transfer therapy targeting oncogenic neoantigens, E Tran
Guidelines for the Neurocritical Care Management of Aneurysmal Subarachnoid Hemorrhage., Miriam M Treggiari, Alejandro A Rabinstein, Katharina M Busl, Meghan M Caylor, Giuseppe Citerio, Steven Deem, Michael Diringer, Elizabeth Fox, Sarah Livesay, Kevin N Sheth, Jose I Suarez, and Stavropoula Tjoumakaris
Leadership Legacy, Sylvain Trepanier
Supporting and Promoting a Diverse Team, Sylvain Trepanier
Experience of New Graduate Nurses in Nurse Residency Programs During the COVID-19 World Pandemic., Sylvain Trepanier, Cory Church, Martha Grubaugh, and LeAnn Ogilvie
The Impact of Accreditation on Nursing Transition Into Practice Residency Programs, Sylvain Trepanier, LeAnn Ogilvie, and Patricia S. Yoder-Wise
Implementing a Virtual Team Model in the Acute Care Setting, Sylvain Trepanier, Sherene Schlegel, Cynthia Salisbury, and Andria Moore
Implementing a Virtual Team Model in the Acute Care Setting., Sylvain Trepanier, Sherene Schlegel, Cynthia Salisbury, and Andria Moore
Calibration of a comprehensive predictive model for the development of proximal junctional kyphosis and failure in adult spinal deformity patients with consideration of contemporary goals and techniques., Peter S Tretiakov, Renaud Lafage, Justin S Smith, Breton G Line, Bassel G Diebo, Alan H Daniels, Jeffrey Gum, Themistocles Protopsaltis, D Kojo Hamilton, Alex Soroceanu, Justin K Scheer, Robert K Eastlack, Gregory Mundis, Pierce D Nunley, Eric O Klineberg, Khaled Kebaish, Stephen Lewis, Lawrence Lenke, Richard Hostin, Munish C Gupta, Christopher P Ames, Robert A Hart, Douglas Burton, Christopher I Shaffrey, Frank Schwab, Shay Bess, Han Jo Kim, Virginie Lafage, and Peter G Passias
Lung Cancer Screening in People With HIV: A Mixed-Methods Study of Patient and Provider Perspectives., Matthew Triplette, Meagan C Brown, Madison Snidarich, Jehan Z Budak, Nicholas Giustini, Nicholas Murphy, Perrin E Romine, Bryan J Weiner, and Kristina Crothers
Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children's Hepatic Tumors International Collaboration (CHIC)., Angela D Trobaugh-Lotrario, Rudolf Maibach, Daniel C Aronson, Arun Rangaswami, Beate Häberle, Allison F O'Neill, Irene Schmid, Marc Ansari, Tomoro Hishiki, Sarangarajan Ranganathan, Rita Alaggio, Ronald R de Krijger, Yukichi Tanaka, Soo-Jin Cho, Christian Vokuhl, Rebecca Maxwell, Mark Krailo, Eiso Hiyama, Piotr Czauderna, Milton Finegold, James H Feusner, Marcio H Malogolowkin, Rebecka L Meyers, and Dolores Lopez-Terrada
Role of Senataxin in Amyotrophic Lateral Sclerosis., Andrew Tsui, Valentina L Kouznetsova, Santosh Kesari, Milan Fiala, and Igor F Tsigelny
2023 Cardiometabolic Health Congress (CMHC) Women’s Health and Wellness Masterclass, Katherine Tuttle
“90% of people with chronic kidney disease don’t know they have it. Do you know the risk factors?”, Katherine Tuttle
“Cardiorenal Disease: Can reducing the risks improve outcomes?”, Katherine Tuttle
Chair – Targeting Muscle, Kidney & Liver, Katherine Tuttle
CKD in Diabetes and the Journey to Kidney Health, Katherine Tuttle
Clinicopathologic Conference “ Nephrotic Syndrome”, Katherine Tuttle
“Comparative effectiveness of GLP-1 receptor agonists vs DPP-4 inhibitors in patients type 2 diabetes, Katherine Tuttle
“Comparative effectiveness of GLP-1 receptor agonists vs. SGLT2 inhibitors”, Katherine Tuttle
Destination Kidney Health for Diabetes and CKD, Katherine Tuttle
Digging deep into cells to find mechanisms of kidney protection by SGLT2 inhibitors., Katherine Tuttle
Effects of Long COVID, Katherine Tuttle
“FDA Approved Empagliflozin for Adults with Chronic Kidney Disease at Risk of Progression”, Katherine Tuttle
“FDA approves new indication for Jardiance”, Katherine Tuttle
“GLP1 RAs and Kidney Outcomes in Diabetes”, Katherine Tuttle
Harvard Medical School – Diabetes Comorbidities and Complications, Katherine Tuttle
“Implementation of a New Era of Goal-Directed Medical Therapy for Patients with Cardiorenal Disease”, Katherine Tuttle
“Incretin Trials: Trying new directions”, Katherine Tuttle
“Jardiance approved for adults with Chronic Kidney Disease”, Katherine Tuttle
KDIGO Conference on CKD, Rome Italy, Katherine Tuttle
Kidney Health in View for Diabetes and CKD, Katherine Tuttle
Late breaking clinical trials: “Asi in CKD”, Katherine Tuttle
Most Powerful Tools Ever to Slow the Progression of Diabetic Kidney Disease: How and When to Use them Optimally”, Katherine Tuttle
Multidisciplinary Strategies for Implementation, Katherine Tuttle
National Academies of Sciences, Engineering, and Medicine, Preparing the Future Workforce in Drug Research and Development Workshop – Speaker, Katherine Tuttle
“ Non-insulin therapies for people living with T2D”, Katherine Tuttle
“On par with the biggest breakthroughs in medicine”, Katherine Tuttle
“Outsize benefit seen in trial of drug for kidney disease”, Katherine Tuttle
“Prediction of kidney failure using multiple data domains in glomerulonephropathy: A CureGN study”, Katherine Tuttle
“Preserving Kidney Health in Diabetes”, Katherine Tuttle
Protective effects of GLP-1 Receptor Agonists, Katherine Tuttle
Providence IM/FM Resident’s Lecture “CKD in Diabetes and Beyond. Entering A New Era of Kidney Health” Spokane, WA, Katherine Tuttle
“Racial and Ethnic Disparities in Acute Care Utilization Among Patients with Glomerular Disease”, Katherine Tuttle
"Randomized trial of semaglutide for diabetic kidney disease in type 1 diabetes", Katherine Tuttle
Research presented at the American Society of Nephrology meeting, Katherine Tuttle
“Safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease”, Katherine Tuttle
“Scientists find promising new drug for chronic kidney disease”, Katherine Tuttle
“SGLT2 inhibitors and GLP-1 receptor agonist: mechanisms of beneficial action beyond, Katherine Tuttle
“Spokane doctor’s breakthrough kidney disease treatment shows promising results”, Katherine Tuttle
“The Journey to Kidney Health is the Reward for People with Diabetes and CKD”, Katherine Tuttle
“The Kidney | SGLT2 Inhibitors and GLP-1”, Katherine Tuttle
“Therapeutic Transformation of Kidney Care by Groundbreaking Clinical Trials”, Katherine Tuttle
“There is no excuse for the number of people we have on dialysis”, Katherine Tuttle
“Tirzepaztide reduces albuminuria in patients with type 2 diabetes”, Katherine Tuttle
“Unmet need: The epidemiology of CKD & type 1 diabetes”, Katherine Tuttle
USPSTF Kidney Caucus Meeting - Speaker, Katherine Tuttle
A Quality Improvement Initiative to Bridge Gaps in Treatment and Interprofessional Care of CKD, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Artificial Intelligence/Machine Learning Consortium to Advance Health Equity and Research Diversity (AIM-AHEAD), Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Assessment of Medication Adherence Among Adults with Glomerular Disease, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Design and Baseline Characteristics of the FIND-CKD Trial: Efficacy of Finerernone on Kidney Disease Progression in People with non-diabetic CKD, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Diabetic Kidney Disease Collaborative (DKD-C): Addressing the Urgent and Unmet Needs of People with CKD, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Dynamic Bayesian Networks (DBN) Predicted ≥40% Decline in eGFR over Six Years, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Incidence of Chronic Kidney Disease in Prediabetes, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Interim Results from FINE-REAL: A Prospective Study Providing Insights into the Use of Finerenone in Routine Clinical Settings, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Kidney Failure Risk Equation Prediction in a Real-World Population with CKD, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Kidney Transcriptomics of Blood Pressure (BP) in Minimal Change Disease (MDC) and Focal Segmental Glomerulosclerosis (FSGS), Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Major Adverse Kidney Disease Events in a Real-World Population with Diabetes, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Predictors of Major Adverse Kidney Disease Events in a Real-World Population with IgA Nephropathy, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Predictors of major adverse kidney disease in a real-world population with IgA nephropathy, Katherine Tuttle, Ken Daratha, Radica Alicic, Joshua J Neumiller, and See all authors in comments
Major adverse kidney disease events in a real-world population with diabetes, Katherine Tuttle, Ken Daratha, Joshua J Neumiller, Radica Alicic, and See all authors in comments
Kidney-Heart Connection: Implications of Chronic Kidney Disease for Screening and Prevention of Heart Failure., Katherine Tuttle and Carolyn S P Lam
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo., Katherine R Tuttle, Heidrun Bosch-Traberg, David Z I Cherney, Samy Hadjadj, Jack Lawson, Ofri Mosenzon, Søren Rasmussen, and Stephen C Bain
The authors reply., Katherine R Tuttle, Heidrun Bosch-Traberg, David Z I Cherney, Samy Hadjadj, Ofri Mosenzon, Søren Rasmussen, and Stephen C Bain
Comparative effectiveness of GLP-1 receptor agonists vs DPP-4 inhibitors in patients with type 2 diabetes and moderate/severe chronic kidney disease, Katherine Tuttle and See all authors in comments
Diabetic Kidney Disease Collaborative (DKD-C): Addressing the urgent and unmet needs of people with chronic kidney disease and diabetes, Katherine Tuttle and See all authors in comments
Indicators of Kidney Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease Treated With Dulaglutide., Katherine Tuttle, Jonathan Matthew Wilson, Yanzhu Lin, Hui-Rong Qian, Federica Genovese, Morten Asser Karsdal, Kevin L Duffin, and Fady T Botros
Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide., Katherine Tuttle, Jonathan Matthew Wilson, Yanzhu Lin, Hui-Rong Qian, Federica Genovese, Morten Asser Karsdal, Kevin L Duffin, and Fady T Botros
